Skip to main content

Edwards Lifesciences Corp Transcatheter Aortic Valve Replacement revenue

  • EW · NYSE
  • Medical devices
  • Health Care Equipment
  • S&P 500
$107.15+1.28%Close 13 Nov 2026 · Market value $61.51B

Transcatheter Aortic Valve Replacement revenue at Edwards Lifesciences Corp came to $1.2B for the quarter to 30 Sep 2026, up 8.0% from a year earlier.

As Edwards Lifesciences Corp reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 4 Nov 2026.

By quarter

$979.4MDec 2023$1.0BMar 2024$1.0BJun 2024$1.0BSep 2024$1.0BDec 2024$1.0BMar 2025$1.1BJun 2025$1.1BSep 2025$1.2BDec 2025$1.2BMar 2026$1.3BJun 2026$1.2BSep 2026
Edwards Lifesciences Corp Transcatheter Aortic Valve Replacement revenue, every reported period
Period endingTranscatheter Aortic Valve Replacement revenueChange on a yearFiled
30 Sep 2026$1.2Bup 8.0%4 Nov 2026
30 Jun 2026$1.3Bup 11.3%4 Aug 2026
31 Mar 2026$1.2Bup 14.4%6 May 2026
31 Dec 2025$1.2Bup 12.0%25 Feb 2026
30 Sep 2025$1.1Bup 12.4%5 Nov 2025
30 Jun 2025$1.1Bup 8.9%6 Aug 2025
31 Mar 2025$1.0Bup 3.8%6 May 2025
31 Dec 2024$1.0Bup 5.8%28 Feb 2025
30 Sep 2024$1.0Bup 6.5%6 Nov 2024
30 Jun 2024$1.0Bup 4.7%31 Jul 2024
31 Mar 2024$1.0Bup 6.3%29 Apr 2024
31 Dec 2023$979.4Mup 12.9%12 Feb 2024
30 Sep 2023$960.9Mup 11.4%27 Oct 2023
30 Jun 2023$991.6Mup 9.3%28 Jul 2023
31 Mar 2023$947.9Mup 7.6%28 Apr 2023
31 Dec 2022$867.7Mdown 0.4%13 Feb 2023
30 Sep 2022$862.3Mup 0.5%28 Oct 2022
30 Jun 2022$906.9Mup 0.6%29 Jul 2022
31 Mar 2022$881.3Mup 11.3%28 Apr 2022
31 Dec 2021$871.5Mup 12.3%14 Feb 2022
30 Sep 2021$857.8Mup 15.2%29 Oct 2021
30 Jun 2021$901.5Mup 51.7%30 Jul 2021
31 Mar 2021$791.7Mup 6.7%28 Apr 2021
31 Dec 2020$776.2Mup 1.8%12 Feb 2021
30 Sep 2020$744.6Mup 6.4%26 Oct 2020
30 Jun 2020$594.3Mdown 12.3%27 Jul 2020
31 Mar 2020$742.2Mup 24.2%28 Apr 2020
31 Dec 2019$762.5Mup 28.9%14 Feb 2020
30 Sep 2019$700.0Mup 25.7%25 Oct 2019
30 Jun 2019$677.7Mup 16.0%26 Jul 2019
31 Mar 2019$597.7Mup 8.5%26 Apr 2019
31 Dec 2018$591.6Mup 13.9%15 Feb 2019
30 Sep 2018$557.1Mup 15.8%26 Oct 2018
30 Jun 2018$584.0Mup 19.8%27 Jul 2018
31 Mar 2018$551.1Mup 2.2%27 Apr 2018
31 Dec 2017$519.3Mup 20.2%16 Feb 2018
30 Sep 2017$481.2Mup 17.3%27 Oct 2017
30 Jun 2017$487.5Mup 16.5%28 Jul 2017
31 Mar 2017$539.2Mup 46.6%28 Apr 2017
31 Dec 2016$432.0Mup 29.2%17 Feb 2017

Definition

Revenue from this part of the business, as the company names and reports it in its results. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.

Other operating KPIs of Edwards Lifesciences Corp: Surgical revenue · Transcatheter Mitral and Tricuspid Therapies revenue · United States revenue · Europe revenue · Rest of World revenue · Japan revenue · financial statements

Every KPI and segment of EW, in the terminal.

Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.